Covenant Asset Management, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Covenant Asset Management, LLC

  • $631 Million
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 02, 2024
SELL
$883.2 - $1071.19 $5.3 Million - $6.43 Million
-6,000 Reduced 37.5%
10,000 $10.5 Million
Q4 2023

Jan 22, 2024
BUY
$775.18 - $881.7 $12.4 Million - $14.1 Million
16,000 New
16,000 $14.1 Million
Q2 2023

Jul 12, 2023
BUY
$700.03 - $830.35 $350,015 - $415,175
500 Added 16.67%
3,500 $2.51 Million
Q1 2023

Apr 27, 2023
SELL
$680.49 - $826.97 $7.28 Million - $8.85 Million
-10,700 Reduced 78.1%
3,000 $2.47 Million
Q4 2022

Jan 24, 2023
BUY
$705.89 - $766.39 $9.67 Million - $10.5 Million
13,700 New
13,700 $0

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Covenant Asset Management, LLC Portfolio

Follow Covenant Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email